Oric Pharmaceuticals, Inc. (ORIC)
NASDAQ · Manufacturing · Pharmaceutical preparations
$13.16−$0.0200 (−0.15%) on the dayAs of the close; data may be delayed.
ORIC price, last 12 months
Key stats
- Previous close
- $13.18
- Open
- $13.00
- Day range
- $12.94 – $13.49
- 52-week range
- $7.23 – $14.93
- Volume
- 2.3M
- Avg volume (20 days)
- 1.4M
- Market cap
- $1.4B
Performance
1W+2.9%
1M−5.4%
3M+38.1%
6M+6.3%
YTD+60.9%
1Y+25.8%
vs S&P 500, 1Y+9.0 pts
Technicals and fundamentals
About Oric Pharmaceuticals, Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $1.4B